Home Innovation That Matters

Innovation That Matters

First Crystal Structure of Human GLUT1 Solved

An article published in the prestigious Nature magazine this summer by a group led by one of a 2012 recipient of WuXi Life Science and Chemistry Awards, Dr. Nieng Yan of Tsinghua University, made a great contribution toward the understanding of GLUT1 functions and...

Antibodies Designed to Combat Ebola May Provide Protection from the Rare but Deadly Infection

New insights about experimental monoclonal antibody cocktails that recognize Ebola virus may soon help provide an effective treatment option.  Ebola virus disease (EVD) is a highly lethal illness in humans that is sometimes associated with bleeding. It is caused by a family of viruses...

Existing Medications for Erectile Dysfunction May Alleviate Symptoms of Duchene Muscular Dystrophy

Duchene muscular dystrophy (DMD) is a rare genetic disorder and is caused by a defect in the dystophin gene.  Insufficient levels of dystophin inhibit the function of nitric oxide, a chemical required for proper blood flow into muscles during exercise. The condition affects 1...

Novira’s Novel Approach to Anti-HBV Drug Discovery

For this month’s Innovation That Matters feature, we interviewed Dr. Osvaldo (Lalo) Flores, CSO of Novira Therapeutics, a leading biotech based in Philadelphia, PA, which is testing novel approaches to anti-hepatitis B (anti-HBV) drug discovery.  Hepatitis B infection presents a significant unmet medical need.  An...

Imbruvica and Its Impact on Patients

For this month’s Innovation That Matters, we interviewed Heow Tan, Chief of Quality and Technical Operations at Pharmacyclics.  Tan joined Pharmacyclics in 2012 and has headed their Global Quality, CMC Development, Global Manufacturing, Supply Chain, and International Operations. Pharmacyclics lead product, ibrutinib, with the...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Acquires ResearchPoint Global to Better Enable Clinical Development Worldwide

We are pleased to announce that WuXi has acquired ResearchPoint Global (RPG), a U..S-based contract research organization (CRO) with expertise spanning across all major...